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Introduction
In childhood, prior to adolescence, vaginal bleed-

ing is only rarely a problem. During adolescence,
however, vaginal bleeding (or the lack of it) is a
common complaint.
The average age of first vaginal bleeding, or menarche, in the United States is between 12.5 and 13
years. Around two years prior to this, however, there
has been budding of breasts and the appearance of
pubic hair. During the year before menarche, there is
pigmentation of the nipples and the breasts fill out.
Axillary hair does not appear until about the same
time as the first menses.
The degree of skeletal maturation is a better indicator of the stage of a girl's development than her
chronologic age. It is generally agreed that most girls
have their first menstrual period when their skeletal
age is between 13.5 and 14 years, regardless of their
chronologic age.
The average menstrual cycle lasts 28 or 29 days,
although cycles from 21 to 40 days are considered
within physiologic limits. The normal human female
usually ovulates between the 11th and 17th day of the
menstrual cycle; this is usually 14 days before the
beginning of the next menstrual flow. The bleeding
usually lasts from 3 to 7 days and blood loss is about
60 ml. Normal menstrual bleeding consists of a sloughing off of the more superficial portions of the endometrium, leaving only the basal layer. This occurs
when the endometrium has been caused to proliferate
by priming with estrogen and then is converted to a
secretory state by progesterone. When the progesterone
is withdrawn, the sloughing or normal menses occurs.
On the other hand, when progesterone has not acted
upon the endometrium (as would be the case if ovulation~had not occurred) and the endometrium has been
stimulated only by estrogen, the woman will not experience menstrual type bleeding. She may experience
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uterine bleeding, but this is usually of an irregular
nature and due to fluctuations in the estrogen level.
When the estrogen level decreases somewhat, the more
superficial portions of the endometrium do not have
adequate hormonal support and break away, often
resulting in heavy and prolonged bleeding. These episodes of bleeding do not occur at any cyclic interval,
and in fact the woman may experience no menses at
all for prolonged lengths of time.
The first vaginal bleeding cycles are commonly
anovulatory. Some authors divide adolescence into
early and late periods using the first ovulation as
the dividing point. They consider early adolescence
synonymous with puberty, beginning with the menarche and ending with the first ovulation, and define
late adolescence as beginning with the first ovulation
and ending when the woman becomes mature. Early
adolescence may last two or more years, but may
never occur if the girl ovulates before her first episode
of vaginal bleeding. The young woman may then pass
rapidly into the state where she is capable of normal
reproduction, although the fact that a human female
is able to produce a fertilizable egg is certainly not to
say that she is mature.

Amenorrhea
If menarche has not occurred by age 16, some investigation is in order. A diagnosis of primary amenorrhea is not usually made until after age 18, but if no
menses have occurred between age 16 and 18, the
condition is called "delayed menarche."
In cases of amenorrhea, a complete history should be
taken, with particular emphasis on symptoms which
could be caused by endocrine pathology or previous
abdominal surgery. The family history should include
menstrual and reproductive histories of the mother
aunts and sisters. Examination of the patient should
include a general physical examination as well as a
pelvic exa~ination. Particular attention should be paid
to lateral visual fields and the thyroid gland. The presence or absence of facial, axillary, pubic, chest and
other body hair should be noted. Breast development
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and general body habitus may also be significant. Some
form of pelvic examination should be done for all
of these girls. Certainly the external genitalia may
be inspected and the clitoris examined. In the vast
majority of these girls, a speculum examination of the
vagina may be done, perhaps using a small speculum.
The cervix may be visualized and a smear taken from
the upper vaginal mucosa for a maturation index of
the superficial cells. A gentle bimanual examination
using one or two fingers is then done, and the uterus
and adnexal areas palpated in this manner. A rectal
examination is done routinely, and in some patients, a
rectal examination will offer the only opportunity for
palpation. In such patients with a small vaginal introitus , inspection of the vagina may be performed
using an endosope such as a culdoscope lens system.
Several conditions may become apparent at the time
of physical examination. The first of these is an imperforate hymen. The hymen is located at the site
where the lower portion of the vagina buds from the
urogenital sinus. If a lumen does not develop at the
point where the vagina arises, the result is an imperforate hymen. Usually these are not discovered until
puberty and symptoms may arise from the accumulation of menstrual blood. Cyclic abdominal pain is a
common symptom, but in some cases large amounts
of blood can accumulate in the vagina, uterus and
tubes without causing great discomfort. On examination, the hymenal membrane may be seen bulging and
a mass will be palpated anteriorly on rectal examination. The treatment of this is simple incision or excision of a triangular flap.
A transverse vaginal septum is a similar condition.
It probably arises as a failure of union between the
downgrowing Mullerian duct and the upgrowing urogenital sinus during embryologic life. In some cases, a
transverse vaginal septum may be associated with a
sinus tract through which the patient menstruates. In
other cases, the septum may be complete and symptoms similar to those of imperforate hymen will be
seen. Usually the septum will occur at the junction of
the upper and middle thirds of the vagina, providing
the girl with a short vagina. Unless the sinus tract is
large enough to dilate, the treatment of this is surgical, the exact procedure being determined by the thickness of the septum. This condition may be confused
with testicular feminization, because in either case
patients appear to be feminine and have short vaginas
with no identifiable cervices. A buccal smear usually
distinguishes the two groups, the patient with the imperforate hymen having a normal female Barr body
present.
Congenital absence of the vagina may also be present. Sometimes these people have a normally developed lower vagina for a few centimeters, but most
times the entire vagina and uterus are absent. The
diagnosis is not usually made in infancy or childhood,
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but instead the patient seeks medical advice because
she has amenorrhea despite the development of normal
secondary sex characteristics and growth. These girls
have ovaries and usually have the upper portion of the
fallopian tubes. These commonly end at about the level
of the uterine cornua, although in some instances a
rudimentary uterus without an endometrial cavity may
be present. Urinary tract anomalies are associated in a
significant number of these patients, so x-ray of the
urinary tract is desirable. An artificial vagina can be
satisfactorily created surgically. Following surgery,
this has a tendency to constrict unless it is kept
dilated, so surgery is deferred until about 6 months
prior to marriage. This allows the operative site time
to heal and during this time the patient wears a foam
rubber dilator, initially all the time, and later only at
night. After marriage, regular coitus is adequate to
maintain dilatation. Some adolescent girls with congenital absence of the vagina will develop psychiatric
problems because of this, and in this group the procedure may be done prior to any plans for marriage,
"to keep her from being different."
In cases of amenorrhea where there is no obvious
physical cause, the initial laboratory work should include a test of thyroid function and a test to exclude
the adrenal as a cause for the amenorrhea. These are
currently done by obtaining serum for free thyroxine
and a 24-hour urine collection for 17-ketosteroids. If
there is any suggestion of Cushing's syndrome from
physical examination or history, a 24-hour urine for 17hydroxysteroids should be collected. If there is any
suggestion of adrenogenital syndrome, a determination
of urinary pregnanetriol would be indicated. As noted
earlier, a maturation index is obtained from the vaginal mucosa.
Once this initial laboratory work has been done,
the patient is given a pure progestin to help establish
the diagnosis of anovulation. If the patient's problem
is simple anovulation, that is, she is producing adequate estrogen but is not ovulating, the addition of a
progestin such as oral medroxyprogesterone 10 mg
daily for 5 days will result in withdrawal bleeding resembling menses several days after the cessation of
treatment. The progestin converts the proliferative
endometrium to secretory endometrium and its withdrawal is then followed by a slough of the superficial
endometrium. If bleeding does occur, this ( 1) suggests there is adequate endogenous estrogen being produced and that anovulation is the problem, (2) establishes the fact that the patient is not pregnant, and
( 3) also establishes the fact that the patient has an
endometrium capable of bleeding and that this blood
has a passageway to escape from the uterus to outside
the body. If the progestin is given and there is no
withdrawal bleeding in 1 week, the patient is then
given an estrogen as well as a progestin. This could be
done by giving her oral norethynodrel 5 mg with
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mestranol 0.075 mg daily for 5 days, or giving ethinyl
estradiol 0.1 mg daily for 14 days with medroxyprogesterone 10 mg daily taken concurrently on days
10 through 14. If this is followed by withdrawal bleeding, this indicates that ( 1) the patient is not producing endogenous estrogen, (2) she is not pregnant, and
( 3) the endometrium is capable of bleeding and the
flow can escape. This is a group of patients in which
the assay of pituitary gonadotropins is useful in establishing the cause of no estrogen production. Total
pituitary gonadotropin in the urine should be either
high or low, but not normal. If the value is high, it
would indicate that this primarily is an ovarian problem, and despite high levels of gonadotropins the ovary
is not producing estrogen. If, on the other hand,
pituitary gonadotropins are low, it would indicate that
the ovary is not being stimulated.
The patients who do not bleed after estrogen and
progestin therapy should be carefully evaluated for a
possible pregnancy. Once this possibility has been excluded, the cervix should be sounded to rule out the
possibility of cervical stenosis and the uterine cavity
probed to establish the fact that there is, indeed, a
cavity to the uterus. In most instances, this can be
done in the office without hospitalization.
Most of the patients seen for amenorrhea will be
found to have anovulation and to be producing adequate endogenous estrogen. They may then be treated
with oral medroxyprogesterone 10 mg daily for 5 days,
beginning cycle day 22 of each month. This will result
in regular withdrawal bleeding, occurring about every
28 days and lasting a normal length of time. When
administered in this way, the drug certainly will not
interfere with spontaneous ovulation, should it occur.
Until spontaneous ovulation does occur, the patient
will experience regular bleeding. Such medication may
be administered for 6 months and then temporarily
discontinued to see what bleeding pattern the patient
will exhibit on her own. After experiencing several
such episodes of bleeding, some girls indicate that they
would rather not be bothered with vaginal bleeding at
monthly intervals. It is beneficial for the superficial
endometrium to experience a slough as normally occurs from a secretory endometrium several times a
year, so this group of girls may be given a progestin
at 4 month intervals until spontaneous menses begin.
The amenorrhea associated with anovulation may be
secondary to psychogenic factors. Psychic shock, fear,
unhappy home or school conditions, and insecurity can
cause both primary and secondary amenorrhea. Sometimes this is associated with simple anovulation but at
other times the patient stops producing estrogen also.
In this latter group, the administration of progestin
alone will not result in withdrawal bleeding and the
patient must receive estrogen priming before such
withdrawal bleeding will occur. If pituitary gonadotropin levels are low in the face of no endogenous

estrogen production, p1tmtary and hypothalamic pathology should be excluded. Old injuries (such as
from high fever or trauma), tumor and pharmacologic
effects should be ruled out. The history, skull x-rays
and visual fields are particularly helpful here. In a few
cases of hypothalamic disease, amenorrhea will be associated with galactorrhea, but such cases are rare.
Other causes of amenorrhea with a hormonal basis
include Turner's syndrome, gonadal dysgenesis without
Turner's syndrome, testicular feminization, adrenogenital syndrome and polycystic ovary syndrome
(Stein-Leventhal syndrome).
In Turner's syndrome, the condition begins with an
accident in miosis or mitosis of the ovum. These
people have only one sex chromosome instead of two,
and when the area normally occupied by ovaries is
examined, usually only a streak of fibrous tissue is
found. Histologically this resembles ovarian stroma
which contains no follicles. These individuals do not
ovulate or produce estrogen or progesterone and their
pituitary gonadotropin levels are high. In addition to
the lack of any secondary sex characteristics and
menstruation, there are associated findings which are
not caused by estrogen lack. These include shortness
of stature, scant pubic and axillary hair, exaggeration
of the carrying angle of the elbow, webbing of the
neck, and coarctation of the aorta. These patients do
have a vagina and uterus, and when exogenous estrogen and progestin are administered, they will develop
secondary sex characteristics and have menses.
Some women will also have streak ovaries which
do not produce estrogen but present an entirely different clinical picture. These women have normal female
sex chromosomes, and all of their findings are secondary to the absence of gonads. The associated findings
of Turner's syndrome are absent. Instead of being
short, these patients are eunuchoid, tall, and h ave an
appearance similar to that seen in persons castrated
prior to puberty. These patients may be also treated
with estrogen and progestin. In these cases, epiphyseal
closure may be promoted and there will also be development of secondary sex characteristics and menses.
Individuals with testicular feminization have the XY
chromosome compliment seen in normal males, but
certainly do not appear to be males. In fact, these
patients on cursory examination appear to be normal
females. They are of normal height, have normal
breast development, and are not hirsute. Pelvic examination will disclose a short vagina and the absence of
a uterus. There is usually scant or absent axillary and
pubic hair and the patient may have an inguinal
hernia or evidence of a previous herniorrhaphy. The
hernias are associated with cryptorchid testes. The
clinical findings are due to a lack of end-organ response to androgens. All testes normally secrete some
estrogen as well as testosterone. In these people with
testicular feminization the testosterone exerts no pe93
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ripheral effect, so estrogen is the only sex hormone
acting, and female secondary sex characteristics develop. Since these cryptorchid testes have a malignant
potential, removal has been advocated, and after castration, testosterone levels fall precipitously and estrogen levels fall somewhat less dramatically. Following
this surgery, most of these patients should be given
replacement estrogen medication.
The adrenogenital syndrome due to congenital adrenal hyperplasia has its onset in intrauterine life. It is
due to enzyme blockage in the adrenals with resulting
elevation of urinary 17-ketosteroids. There are several
types of this syndrome, but the most common one has
a partial block in the synthetic pathway for cortisol
resulting in the production of 17-ketosteroids and
pregnanetriol. In addition to the amenorrhea, these
people will have early development of hirsutism, accelerated development in length and weight, advanced
bone age on x-ray and associated virilization. Treatment with cortisol will result in the onset of ovulatory
menses and in many cases reduction of the hirsutism.
When hirsutism is associated with amenorrhea, one
should also exclude adrenal and ovarian tumors as
well as Cushing's syndrome.
Patients with polycystic ovary syndrome will have
bilaterally enlarged polycystic ovaries and failure of
ovulation. Typically, a girl goes through normal early
adolescence and may even ovulate for a time before
stopping. In some cases there may be no spontaneous
menses. Hirsutism may be mild or severe; but virilization does not occur. The ovaries in this condition are
about two to four times normal size and contain many
small follicles beneath the capsule. The primary defect,
however, is not thought to be in the ovary, but in the
hypothalamus or higher centers resulting in an improper secretion of pituitary gonadotropins. The traditional treatment for polycystic ovary syndrome was
wedge resection of the ovaries. In some manner, reduction of ovarian mass changed the feedback effect
on the hypothalamus, and pituitary gonadotropins
were then secreted in a proper ratio. Such effects did
not last forever, and commonly after a year or so of
ovulatory menses, the original condition returned.
More recently, it has been possible to induce ovulation
in most of these women by the use of clomiphene
citrate or menopausal gonadotropin. This is given only
during the months when pregnancy is desired. In order
to have regular menses at other times, withdrawal
bleeding from exogenous sex steroids may be utilized.
In most cases, sequential estrogen-progestin is given
here, because the estrogen has a beneficial effect on
the hirsutism; the progestin then induces a secretory
change in the endometrium resulting in a menstrual
type slough when the progestin is withdrawn. In some
cases, the estrogen is given continuously; in others,
both estrogen and progestin may be stopped on the
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same date, with the estrogen therapy being resumed
one week later.
Menorrhagia and Metrorrhagia
Anovulation may also manifest itself by episodes
of frequent, heavy or prolonged vaginal bleeding. The
work up and long-term therapy of such patients is the
same as when the primary symptom was amenorrhea.
There is in addition, however, the initial problem of
getting the bleeding stopped. Dilatation and curettage
of the uterus is only rarely needed. Most of these girls
will stop bleeding when treated with estrogen. Their
bleeding has occurred when their circulating estrogen
level has dropped, so they may be logically treated by
exogenous estrogen. In some cases, oral estrogen is
adequate therapy. In other cases, when hemorrhage
has been profuse, bleeding may be controlled by the
administration of intravenous conjugated estrogens 20
mg, repeated once in 6 hours if necessary. At the same
time that intravenous therapy is given, oral medication
is also started. The patient may be given oral conjugated estrogens 1.25 mg three times a day, ethinyl
estradiol 0.1 mg daily, or any of the commercially available oral contraceptive tablets (preferably those with
higher estrogen content). When oral estrogen alone is
given, the patient should take this medication for 21
days and on the last 5 days should take medroxyprogesterone 10 mg. This will cause secretory changes
in the estrogen stimulated proliferative endometrium
and will result . in normal type bleeding when both
estrogen and progestin are withdrawn. In subsequent
months, medroxyprogesterone alone administered 10
mg a day for 5 days, beginning cycle day 22, is usually adequate to prevent abnormal bleeding.
Dysmenorrhea
P ainful menstruation during adolescence is usually
primary; that is, it is not associated with congenital
anomalies or organic disorders. Such discomfort usually does not appear until several years after the
menarche, and is thought to appear at the same time
that the girl begins to ovulate and have ovulatory
menses rather than while she is having anovulatory
bleeding episodes. A distinction was previously made
between early and late adolescence on a basis of
whether menses were ovulatory. If that classification
is retained, primary dysmenorrhea is a symptom of
late adolescence.
Dysmenorrhea pain is recurrent, sharp, and cramping or contraction like in character. It is usually
located in the suprapubic area and may precede the
onset of flow, may not occur until bleeding actually
occurs, or may not appear until after bleeding has
been established for several days. Associated symptoms may include malaise, headache, backache and
lethargy. Since this is usually associated with ovulatory menses, these girls usually do not have any his-
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tory of menstrual irregularity, but instead have quite
regular menses.
The cause of primary dysmenorrhea is not known.
It most likely has something to do with uterine contractions, but the exact nature of this is not clear. In
addition, there seems to be some psychogenic influence
in that some girls have been conditioned in childhood
by their mothers or older sisters to look upon menstruation as "being sick." Physical examination, of
course, should be done, in an effort to rule out any
organic or congenital obstruction to menstrual flow.
The milder cases can be treated with a combination
of mild analgesics and amphetamine. Such medication
should not be taken at night, but the effects of amphetamines as a uterine muscle relaxant are beneficial
and useful during daytime. If the patient continues to
has severe symptoms, the use of an estrogen-progestin
combination oral contraceptive agent is useful. This
inhibits ovulation, but supplies exogenous progestin.
How this prevents dysmenorrhea is unclear, but it does
so in a majority of these patients. Some physicians
worry about the propriety of giving a medicatiOn
which can be recognized as a contraceptive agent to an
adolescent girl, fearing that if she knows the effects of
the medication this will inspire her to engage in premarital coitus. As other contraceptive methods are
readily available over-the-counter at drugstores and
even at discount stores, the availability to her of another contraceptive method is not likely to influence
the girl's social behavior. Since combination oral contraceptive agents have been used for this purpose, the
number of presacral neurectomies done to relieve
dysmenorrhea has diminished greatly.
Mittleschmerz or ovulatory pain also is a symptom
of late adolescence as opposed to early adolescence.
The discomfort is usually described as a slight aching in one side of the lower abdomen, although it may
be quite severe. At times, it is so severe that when it
is located on the right side, the possibility of appendicitis is seriously entertained. The cause of midcycle
pain is unknown. Moderate amounts of free blood do
not cause peritoneal pain, but in some manner the
peritoneum becomes irritated. The menstrual history
and the time of occurrence of the pain are most useful
in making the diagnosis.
Leukorrhea
Not all vaginal discharge is pathologic. Increased
vaginal fluid is very common in adolescent girls. The
girl may interpret the normal estrogen stimulated
secretion of the endocervical glands as a pathologic
condition. In a normal ovulatory cycle, such secretion
is greatest at the time of highest unopposed estrogen
levels, that is immediately before ovulation. In early
adolescence, estrogen is the only hormone which is
acting upon the endocervical glands, and such secretion may be present continuously. When the girl begins

to ovulate, such secretion will diminish and will be of
increased volume for only several days each month.
The second most common cause of leukorrhea in
adolescent girls is infection with Candida albicans.
The increased incidence in diabetic females is well
known. Systemic antibiotic therapy may be followed
by Candida infection, and pregnancy as well as therapy with oral estrogen-progestin contraceptive tablets
may also predispose to this. The scanty discharge is
thick, white and curd-like in appearance. In addition
to leukorrhea, the patient may have vaginal and vulvar
puritis with associated excoriation on the vulvar
areas. The diagnosis can usually be made by inspection
of the vagina and may be confirmed by culture on Nickerson's media. Culture tubes containing Nickerson's
media are available commercially and may be incubated at room temperature for 2 days and subsequently examined in the physician's office.
Infections may be treated first with nystatin vaginal
suppositories which are inserted twice daily for 12
days. If vulvitis is also a symptom, nystatin cream is
applied here. If the nystatin does not clear up the
infection, gentian violet may be used. This is highly
effective in eliminating the condition but the purple
staining of undergarments, bed sheets and towels may
be a problem.
Vaginal trichomoniasis is relatively uncommon in
the younger adolescent. It becomes more common as
the girls grow older and is particularly common in
girls who have had intercourse. On the other hand, the
number of cases in which vaginal trichomoniasis occurs without the possibility of direct sexual contact
with an infected male is so large that we must consider this a disease that can be transmitted several
ways, only one of which is by coitus. The girl will
complain of an irritating profuse discharge. There may
be perinea! itching or burning with micturition and
sometimes the symptoms are worse just before and
immediately after menses. On examination the vagina
is filled with a copious frothy, watery, dirty ivory colored fluid. When the vaginal mucosa is involved
severely, a strawberry or red punctate vaginal erup~
tion may be seen, but many cases of vaginal trichomonous exist without this finding. The diagnosis is
made by finding Trichomonas vaginalis in wet smears
of the vaginal fluid. The fluid should be examined
immediately after being diluted with warm isotonic
saline solution. Hypotonic solutions as well as cooling,
drying or changes in the pH will quickly kill the
organisms. The organisms, which are protozoa, may
be seen swimming about on the wet smear. Vaginal
trichomoniasis may be treated with metronidazole 250
mg three times a day for 10 days.
Non-specific vaginal inflammations are commonly
associated with leukorrhea in adolescent girls. There
is little or no irritation or discomfort due to this
leukorrhea except that there may be some dysuria.
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There is usually no vulvar inflammation, but the
vagina is inflammed and the discharge varies from a
scanty thin fluid to a purulent grayish-yellow leukorrhea which is profuse enough to necessitate the wearing of perineal pads. These cases, as well as mixed
infections with monilia or trichomonas, may be
treated with vaginal suppositories of furazolidone with
nifuroxinie. Sometimes the non-specific vaginitis is
associated with a congenital cervical erosion or an
erosion which is secondary to the vaginitis. Such erosions do not usually need cautery and if they are
secondary to the vaginitis, they clear up when the
vaginitis clears.
Venereal Disease
Acute gonorrhea is accompanied by a profuse purulent, yellowish green discharge. This will appear 3-8
days after the girl has had coitus with an infected
male and may be associated with dysuria or vulvar
burning. In some cases there is very little discomfort.
The profuse, thick, creamy vaginal discharge may persist after the acute symptoms have gone away and
may be seen to be coming primarily from an eroded
cervix. There may be associated infection of the
Bartholin's glands or of the periurethral glands. Unfortunately, female patients are not as aware as males
of a urethral discharge and 80 % of females with
gonorrhea are asymptomatic. The gonococcus usually
does not rise above the internal uterine os except
during menses and this results in symptoms of acute
salpingo-oophoritis commonly occuring just after
menses. The patient will have bilateral lower abdominal pain and tenderness, adnexal thickening and tenderness, fever and leukocytosis. Pelvic peritonitis, with
rebound tenderness and a palpable abscess in the tube
or ovary may be associated findings. Gram stain may
be applied to smears, and cultures may be made on
the new Theyer-Martin or Lesser-Martin culture
media which is most specific for gonococcus. The results are available in 48 hours, and as a screening
technique this method will pick up about 90 % of the
cases. It is probably best to take smears from the
cervix, vagina, urethra and rectum. The treatment of
acute gonorrhea in the female is a single injection of
4.8 million units of procaine penicillin G .
Patients with gonorrhea should also be examined
for syphilis, using the absorbed flourescent Treponema
antibody test. This becomes positive in about 20 days
after exposure, so it is positive during the time of the
primary lesion. The presence of a chancre on the
vulva, in the vagina or on the cervix, is rarely noted
and the manifestations of secondary syphilis may be
the first symptoms noted by the patient. The primary
lesion, or chancre, develops at the site of innoculation,
3 to 6 weeks after the Treponema pallidum enters the
body. It rarely is a well-defined punched out ulcer
with a hard base, as seen in the male, but may be a
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painless, flat, moist abrasion or a flat, superficial,
excoriated type of ulcer. The chancre heals spontaneously, and about 6 weeks after its appearance,
secondary syphilis may appear. This is typically manifested as a symmetrical, macular, papular, non-irritating rash which may involve the palms and soles as
well as the trunk and extremities. Other findings include mucous patches of the oral mucosa, condylomata
lata, iritis or neurorectinitis, alopecia, generalized
lymphadenopathy, and constitutional symptoms such
as malaise, lassitude, headaches and fever. The VDRL
( cardiolipin) test is positive by the time secondary
syphilis is noted. The treatment of primary or secondary syphilis is a single injection of 2.4 million units
of benzathine penicillin G.
Rape
From time to time, girls allege that rape has occurred and they seek medical attention. If the victim
is not brought in by the police, officials should be
notified. The definition of rape varies from state to
state. In Maryland, for instance, penetration of the
vagina by the penis is required, but in the Commonwealth of Virginia rape occurs when force is used to
cause contact of genitalia without consent of the person being raped. Statutory rape, on the other hand,
occurs when the girl gives consent to coitus but is 15
years of age or under.
An evaluation for suspected rape should include a
good history, which should be obtained and written
down as quotations in the patient's words. The time,
place and circumstances should be recorded, as well
as the patient's emotional state and whether a bath had
been taken since the incident occurred. The examination should include a statement concerning the general appearance of the patient including evidence of
trauma such as bruises, lacerations or torn clothes.
Particular attention should be paid to evidence of
trauma about the external genitalia. A speculum examination should then be carried out with a nonlubricated speculum. A cotton swab should be saturated with fluid present in the vaginal cavity. A small
portion of this should be put on each of two glass
slides and allowed to dry. The swab should then be
placed in a test tube and sealed with a cork. These
specimens will be examined microscopically for sperm
and biochemically for acid phosphatase. These specimens, along with any garments that appeared to contain stain, should be labeled with the name of the
victim, date and hour of alleged rape, hour of medical examination and name of physician. All of this
"evidence" should be securely kept under lock until
arrangements have been made for transfer to a designated local laboratory or to the office of the Chief
Medical Examiner. If it is to be mailed, certified mail
or insured mail with return receipt should be used.
The oral administration of 25-50 mg of stilbestrol a

J. A. BOARD
day for 5 days or the oral administration of 2-5 mg a
day of ethinyl estradiol for 5 days, beginning therapy the day after coitus, consistently prevents implantation. The primary side effect with this therapy
is nausea and vomiting. Sometimes this is quite severe,
in spite of the concomitant administration of antiemetic agents. The nausea and vomiting, however, is
usually experienced on the first day of therapy and the
remaining 4 days are associated with this symptom. The patient may experience breast soreness and
the first menses after therapy may be associated with
menorrhagia. The mechanism of action is still unclear.
The expected basal body temperature rise is frequently
inhibited, and the endometrial histologic picture does
not progress normally. Perhaps the endometrium is
made more acid, and this contributes to failure of
implantation.
Since the attacker may have had a venereal disease,
some physicians give prophylactic antibiotic therapy.
If there is no indication of penicillian allergy, 2.4 million units of benzathine penicillin may be used .
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